Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

Post time 7 day(s) ago

journal：European Journal of Cancer

Authors：David J. Pinato; Thomas U. Marron; Pallavi Shruti Mishra-Kalyani; Yutao Gong; Guo Wei; David Szafron; Elad Sharon; Anwaar Saeed; Tomi Jun; Sirish Dharmapuri; Abdul R. Naqash; Thoetchai Peeraphatdit; Anuhya Gampa; Yinghong Wang; Uqba Khan; Mahvish Muzaffar; Musharraf Navaid; Chieh J. Lee; Pei-Chang Lee; Anushi Bulumulle; Bo Yu; Sonal Paul; Neil Nimkar; Dominik Bettinger; Hannah Hildebrand; Yehia I. Abugabal; Tiziana Pressiani; Nicola Personeni; Antonio D'Alessio; Ahmed O. Kaseb; Yi-Hsiang Huang; Celina Ang; Julie Schneider; Anjana Pillai; Lorenza Rimassa; Kirsten B. Goldberg; Richard Pazdur; Marc Theoret; Steven Lemery; ‘Lola Fashoyin-Aje; Alessio Cortellini; Lorraine Pelosof

Published date：2021-11-

DOI：10.1016/j.ejca.2021.08.020

PDF link：https://www.sciencedirect.com/sc ... 959804921005372/pdf

Article link：https://doi.org/10.1016/j.ejca.2021.08.020

Article Source：Elsevier BV。

Remark：

Post time 7 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice Copy